IL6 and colitis: Also, these compounds possess anti-inflammatory properties, suppressing inflammatory pathways involved in colitis and inhibiting the NLRP3 inflammasome, thereby reducing pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α [48].